1. Home
  2. JNVR vs NLSP Comparison

JNVR vs NLSP Comparison

Compare JNVR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • NLSP
  • Stock Information
  • Founded
  • JNVR 2018
  • NLSP 2015
  • Country
  • JNVR United States
  • NLSP Switzerland
  • Employees
  • JNVR N/A
  • NLSP N/A
  • Industry
  • JNVR Finance: Consumer Services
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • JNVR Finance
  • NLSP Health Care
  • Exchange
  • JNVR Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • JNVR 8.9M
  • NLSP 8.2M
  • IPO Year
  • JNVR 2023
  • NLSP 2021
  • Fundamental
  • Price
  • JNVR $0.76
  • NLSP $0.22
  • Analyst Decision
  • JNVR
  • NLSP Hold
  • Analyst Count
  • JNVR 0
  • NLSP 1
  • Target Price
  • JNVR N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • JNVR 1.0M
  • NLSP 11.6M
  • Earning Date
  • JNVR 07-16-2024
  • NLSP 07-30-2024
  • Dividend Yield
  • JNVR N/A
  • NLSP N/A
  • EPS Growth
  • JNVR N/A
  • NLSP N/A
  • EPS
  • JNVR N/A
  • NLSP N/A
  • Revenue
  • JNVR $1,947,052.00
  • NLSP N/A
  • Revenue This Year
  • JNVR N/A
  • NLSP N/A
  • Revenue Next Year
  • JNVR N/A
  • NLSP N/A
  • P/E Ratio
  • JNVR N/A
  • NLSP N/A
  • Revenue Growth
  • JNVR N/A
  • NLSP N/A
  • 52 Week Low
  • JNVR $0.70
  • NLSP $0.11
  • 52 Week High
  • JNVR $5.50
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 40.44
  • NLSP 59.06
  • Support Level
  • JNVR $0.71
  • NLSP $0.19
  • Resistance Level
  • JNVR $0.80
  • NLSP $0.22
  • Average True Range (ATR)
  • JNVR 0.10
  • NLSP 0.03
  • MACD
  • JNVR 0.00
  • NLSP 0.00
  • Stochastic Oscillator
  • JNVR 12.07
  • NLSP 58.54

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: